CLINICAL STUDIES: INTERVENTIONAL CARDIOLOGY
Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction
Frits Bär, MD, PhDa,
Jindra Vainer, MDa,
Jeroen Stevenhagen, MSc*,
Kars Neven, MSc*,
Rob Aalbregt, MSc*,
Ton Oude Ophuis, MD, PhD ,
Vincent van Ommen, MD, PhDa,
Hans de Swart, MDa,
Ebo de Muinck, MD, PhDa,
Willem Dassen, PhDa and
Hein Wellens, MD, PhD, FACCa
a University Hospital Maastricht and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands
* Maastricht University, Maastricht, The Netherlands
Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands
Manuscript received March 23, 1999;
revised manuscript received February 16, 2000,
accepted March 27, 2000.
Reprint requests and correspondence: Dr. Frits Bär, Department of Cardiology, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands f.baer{at}cardio.azm.nl
OBJECTIVES
How effective and safe is rescue percutaneous transluminal coronary angioplasty [PTCA] compared with primary PTCA, and is it cost effective?
BACKGROUND
In acute myocardial infarction (AMI), primary PTCA has been shown to be beneficial in terms of clinical outcome. In contrast, the value of rescue PTCA has not been established.
METHODS
In a retrospective analysis, we compared the angiographic and clinical outcomes of 317 consecutive patients who had rescue PTCA 90 min after failed thrombolysis and 442 patients treated with primary PTCA. An estimation of interventional costs was compared with the strategies of primary and rescue PTCA or with the strategy of thrombolysis with rescue PTCA, when indicated.
RESULTS
Baseline characteristics between primary and rescue PTCA were comparable for most variables. Treatment delay was longer for patients who had rescue PTCA: 240 min. versus 195 min. Coronary patency after PTCA was comparable: 90.2% for rescue PTCA and 91.4% for primary PTCA (p = 0.67, power 71.9%). In-hospital mortality rates were 4.7% and 6.6%, respectively (p = 0.37). Also, the other complications were fairly similar during the in-hospital phase and during one-year follow-up. Predictors of death were age, infarct size, localization of AMI, failed PTCA and left main stem occlusion. The estimated interventional costs during one-year follow-up were $7,377 for primary PTCA and $8,246 for rescue PTCA: difference $869 (11.7%).
CONCLUSIONS
In this retrospective analysis of 759 patients with AMI, rescue angioplasty early after failed thrombolysis seems to be as effective and safe as primary PTCA. In the present evaluation, interventional costs of primary PTCA are less than those of rescue PTCA (p = 0.0001).
|
Abbreviations and Acronyms
| | AMI | = acute myocardial infarction | | ECG | = electrocardiographic | | GUSTO | = Global Use of Strategies To Open occluded arteries trial | | LCx | = left circumflex coronary artery | | LIMI | = LImburg Myocardial Infarction trial | | PACT | = Plasminogen activator Angioplasty Compatibility Trial | | PTCA | = percutaneous transluminal coronary angioplasty | | TIMI | = Thrombolysis In Myocardial Infarction trial |
|
This article has been cited by other articles:

|
 |

|
 |
 
A G C Sutton, P G Campbell, R Graham, D J A Price, J C Gray, E D Grech, J A Hall, A A Harcombe, R A Wright, R H Smith, et al.
One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial
Heart,
October 1, 2005;
91(10):
1330 - 1337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. C. Sutton, P. G. Campbell, R. Graham, D. J. A. Price, J. C. Gray, E. D. Grech, J. A. Hall, A. A. Harcombe, R. A. Wright, R. H. Smith, et al.
A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: The Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial
J. Am. Coll. Cardiol.,
July 21, 2004;
44(2):
287 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. S. Mahadevan, D. McCarty, and A. A. J. Adgey
Platelet GPIIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies
Eur. Heart J.,
October 1, 2002;
23(19):
1490 - 1491.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ronner, R.T. van Domburg, M.J.B.M. van den Brand, P.J. de Feyter, D.P. Foley, W.J. van der Giessen, P.W. Serruys, and M.L. Simoons
Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies. A single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction
Eur. Heart J.,
October 1, 2002;
23(19):
1529 - 1537.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|